Stay updated on Pembrolizumab and Radiotherapy in Melanoma: Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab and Radiotherapy in Melanoma: Clinical Trial page.

Latest updates to the Pembrolizumab and Radiotherapy in Melanoma: Clinical Trial page
- Check4 days agoChange DetectedThe metadata section loses the 'Melanoma' tag and related topic links (MedlinePlus Genetics), removing cross-links to related resources while leaving the main study information unchanged.SummaryDifference0.2%

- Check12 days agoChange DetectedAdded related topics: Melanoma and MedlinePlus Genetics, and updated the revision tag from v3.6.5 to v3.6.6.SummaryDifference0.2%

- Check19 days agoChange DetectedThe related topics/MeSH terms section was updated to remove Melanoma and MedlinePlus Genetics, narrowing the disease and genetics topics tied to this study. This change impacts how the study is indexed and discovered rather than altering the study details shown to users.SummaryDifference0.2%

- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedThe revision label was updated from v3.6.4 to v3.6.5, indicating a newer version of the study record. This change represents an update to the document version rather than substantive content changes.SummaryDifference0.1%

- Check47 days agoChange DetectedAdded Melanoma and related topics (MedlinePlus Genetics) as new metadata entries. Updated the revision tag from v3.6.3 to v3.6.4.SummaryDifference0.2%

- Check61 days agoChange DetectedRemoves the melanoma reference from the study page’s content. Eliminates the Related topics section, including the MedlinePlus Genetics link.SummaryDifference0.2%

Stay in the know with updates to Pembrolizumab and Radiotherapy in Melanoma: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Radiotherapy in Melanoma: Clinical Trial page.